trending Market Intelligence /marketintelligence/en/news-insights/trending/beq2m_xc5yjh3pndjs8-1a2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

DiaMedica raises additional $2.5M to fund drug trial

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

DiaMedica raises additional $2.5M to fund drug trial

Minneapolis' DiaMedica Therapeutics Inc. raised additional gross proceeds of $2.5 million through a private placement of 10,534,059 units priced 24.5 cents each.

The biopharmaceutical company had previously raised $3.8 million and plans to use the $6.3 million to complete a mid-stage study of its drug DM199 to treat acute ischemic stroke.